Christophe Bourdon, Leo Pharma CEO
Leo Pharma says its yearslong makeover is about to pay off
For the first time since 2018, dermatology-focused Leo Pharma projects that it could turn a profit this year.
Its Wednesday guidance comes on the heels …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
